The HFMA has announced that Robert Taylor of member company Vitabiotics is its new chair, supported by Ray Myers of Wassen as the new vice-chair. Taylor will succeed former chair, Lynn Lord, who is standing down at the end of an eventful and successful one-year term.
Graham Keen, executive director, commented: “Lynn has played an important role in helping the HFMA achieve real progress on key issues affecting our industry over the past year. We warmly thank Lynn for a job well done over what has been a challenging 12 months for the Association, culminating in the successful outcome of the recent glucosamine Judicial Review. Robert steps in having already contributed many years as a member of the Council, and as vice-chair last year, to help drive the Association at this important time as the HFMA approaches its 50th anniversary next year.”
Commenting on the HFMA’s task ahead, Robert Taylor said: “As chair I hope to help continue the work of increasing the positive profile of the HFMA in the UK and Brussels with policy makers and regulators, with the ultimate aim of minimising the damage of overly-restrictive new EU legislation. This can only be achieved by being more closely involved when new legislation is first being formed and to build alliances to lobby effectively against the challenges we already face
“On a practical level, I know how important it is for member companies, who are under huge time and resource pressures, to find their way through the seemingly impossible amount of new European regulations. So I hope I can help HFMA to do even more in translating this legislation into easy-to-digest information and summaries that can be cascaded down to all levels within the member company for timely action when needed.”
